Latest Financials News

Page 250 of 1642
InFocus Group Holdings Limited reported a 37% revenue increase to AUD 2.74 million for H1 FY26, alongside a substantial net loss of nearly AUD 3 million, as it invests in new digital asset and iGaming ventures.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Orion Equities reported a modest loss of $11,051 for the half-year ending December 2025, with net tangible asset backing per share holding steady at $0.42. The company’s investment portfolio, notably in Strike Resources and Bentley Capital, remains central to its financial position.
Victor Sage
Victor Sage
27 Feb 2026
Mayfield Childcare Limited reported a modest revenue increase for 2025 but suffered a dramatic net loss and faced an audit qualification over related party disclosures.
Victor Sage
Victor Sage
27 Feb 2026
Pure Foods Tasmania reports a $6.85 million half-year loss, driven by a strategic operational reset and loan covenant breach, while showing signs of stabilisation and margin improvement.
Victor Sage
Victor Sage
27 Feb 2026
Resolute Mining Limited reported a robust financial turnaround in 2025, posting a $126.7 million net profit driven by higher gold prices and cost efficiencies despite lower production volumes. The granting of the Doropo mining permit and strategic asset sales mark key milestones in its West African expansion.
Maxwell Dee
Maxwell Dee
27 Feb 2026
ClearVue Technologies reported a 9% reduced half-year loss of $5.25 million, while pushing forward with significant advancements in its solar glass technology and expanding global licensing partnerships.
Victor Sage
Victor Sage
27 Feb 2026
Argent BioPharma reported a significantly reduced half-year loss of A$2.9 million, progressing a strategic acquisition to bolster its CannEpil drug pipeline and securing up to A$11 million in new funding.
Ada Torres
Ada Torres
27 Feb 2026
SDI Limited reported a modest 2% dip in net profit for H1 FY26 despite a 2.7% rise in sales, driven by growth in aesthetics and exports. The company faces challenges from regulatory bans on Amalgam products while advancing plans for manufacturing upgrades and a potential acquisition.
Ada Torres
Ada Torres
27 Feb 2026
Recce Pharmaceuticals reported a doubling of its net loss for the half-year ended December 2025 amid significant progress in its anti-infective drug development and a substantial funding boost. The company is advancing Phase 3 trials and expanding its patent portfolio while managing financial pressures.
Ada Torres
Ada Torres
27 Feb 2026
Michael Hill International reported a 3% rise in group sales and a 28.6% jump in comparable EBIT for the half-year ended December 2025, driven by strong performances across Australia, Canada, and New Zealand. Despite improved earnings and cash flow, the board has opted to withhold an interim dividend, signalling cautious optimism.
Logan Eniac
Logan Eniac
27 Feb 2026
Pointerra Limited reported a $2.14 million loss for the half-year ending December 2025 amid a 51% revenue decline, yet the company highlights promising contract wins and a growing recurring revenue base that could drive a turnaround in the second half.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Vinyl Group Ltd has reported a robust 49% increase in revenue for the first half of FY26, alongside a significant reduction in net loss, driven by strategic acquisitions and AI integration.
Victor Sage
Victor Sage
27 Feb 2026